Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00610207 · ClinicalTrials.gov registry record · NA

Treatment of Crohn's Fistula Using a Porcine Intestine Submucosa Graft

A NA study, sponsored by Cook Group Incorporated.

Terminated
Registry status
NA
Development phase
21
Enrollment target

NCT00610207 is a NA study that was terminated before completion, run by Cook Group Incorporated. The registered enrollment target is 21 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00610207, a NA study, was terminated before completion, sponsored by Cook Group Incorporated.

TERMINATED
Registry status
NA
Development phase
21 participants
Enrollment target

Study Summary

Healing anal fistulas in Crohn's patients with an anal fistula plug.

Interventions

  • DEVICE Surgisis Biodesign Anal Fistula Plug (SurgiSIS AFP)

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2007-03
Est. Completion 2010-04
Phase NA

Sponsor

Cook Group Incorporated

31 total trials

What the Registry Record Tells You About NCT00610207

The ClinicalTrials.gov registry entry for NCT00610207 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cook Group Incorporated, which has 31 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Surgisis Biodesign Anal Fistula Plug (SurgiSIS AFP) is the first listed.

NCT00610207 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00610207 about?

NCT00610207 is a clinical study titled "Treatment of Crohn's Fistula Using a Porcine Intestine Submucosa Graft". Healing anal fistulas in Crohn's patients with an anal fistula plug.

What is the current status of trial NCT00610207?

This trial is currently terminated. It is a NA study. The enrollment target is 21 participants. The study started on 2007-03. Estimated completion is 2010-04.

What interventions are being tested in trial NCT00610207?

The interventions under investigation include: Surgisis Biodesign Anal Fistula Plug (SurgiSIS AFP) (DEVICE).

Who is sponsoring clinical trial NCT00610207?

This trial is sponsored by Cook Group Incorporated, which has 31 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.